ArticleAAPS PharmSciTech2026
Solubility-Permeability-Matrix Interplay in Percutaneous Absorption Exemplified by Theophylline.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The stratum corneum represents the main barrier to transdermal drug delivery, particularly for hydrophilic and ionized compounds such as aminophylline. In this study, the solubility-permeability-matrix interplay was investigated using aminophylline and theophylline as model drugs in various matrix-type transdermal patches based on either hydroxypropyl methylcellulose (HPMC) or silicone-based Bio-PSA (Biomedical Pressure-Sensitive Adhesive). Franz diffusion cells with porcine ear skin were used to evaluate in vitro skin permeation, and complementary release studies were conducted using dialysis membranes. Aminophylline exhibited significantly higher transdermal flux than theophylline in both matrix systems, despite its increased hydrophilicity and ionization. This effect is attributed to its capacity to maintain high thermodynamic activity when formulated as a suspension, thereby intensifying chemical potential gradients and supporting aqueous pathway permeation. Penetration enhancers showed distinct mechanisms of action. Geraniol, a lipophilic terpene alcohol, significantly increased skin permeation by disrupting stratum corneum lipid lamellae and facilitating transient hydrophilic channels. In contrast, Transcutol P acted primarily by increasing drug solubility within the matrix and forming a reservoir in the stratum corneum. However, its enhancing effect remained modest due to limited interaction with the barrier and slow release from the silicone matrix. These findings highlight the critical role of drug solubility and enhancer molecular properties in the transdermal delivery of hydrophilic drugs. In addition, matrix parameters like thickness, hydration and release properties need to be properly engineered for making optimal use of the involved solubility-permeability interplay.
Indexed as
Identifiers
41792385What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.